-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation